Role of chemokines in promoting instability of coronary atherosclerotic plaques and the underlying molecular mechanism

Brazilian Journal of Medical and Biological Research

Volumn 48, Issue 2, 2015, Pages 161-166

  Zhong, Z X ^a   Li, B ^a   Li, C R ^a   Zhang, Q F ^a   Liu, Z D ^a   Zhang, P F ^a   Gu, X F ^a   Luo, H ^a   Li, M J ^a   Luo, H S ^a   Ye, G H ^a   Wen, F L ^a  

^a MEIZHOU HOSPITAL AFFILIATED TO SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atherosclerosis; Chemokine; MCP 1; Plaque; RANTES

Indexed keywords

BETA ACTIN; C REACTIVE PROTEIN; CHEMOKINE; FRACTALKINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; ANGIOCARDIOGRAPHY; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL VIABILITY; CHEMOTAXIS; CHEMOTAXIS ASSAY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; VASCULAR REMODELING; ANGINA PECTORIS; BLOOD; CORONARY ARTERY DISEASE; ENDOSCOPIC ECHOGRAPHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANGINA PECTORIS; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CX3CL1; CHEMOKINES; CHEMOTAXIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PLAQUE, ATHEROSCLEROTIC; REAL-TIME POLYMERASE CHAIN REACTION; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84922250605     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20144195     Document Type: Article

References (25)

1. Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ. Chronic kidney disease is associated with increased coronary artery atherosclerosis as revealed by multidetector computed tomographic angiography. Tex Heart Inst J 2012; 39: 811-816.
2. Thej MJ, Kalyani R, Kiran J. Atherosclerosis in coronary artery and aorta in a semi-urban population by applying modified American Heart Association classification of atherosclerosis: An autopsy study. J Cardiovasc Dis Res 2012; 3: 265-271, doi: 10.4103/0975-3583.102692.
3. Khan R, Jang IK. Evaluation of coronary allograft vasculopathy using multi-detector row computed tomography: a systematic review. Eur J Cardiothorac Surg 2012; 41: 415-422, doi: 10.1016/j.ejcts.2011.06.033.
4. Babic S, Nezic D, Radak D. Is the routine screening for significant atherosclerotic renal artery stenosis during coronary angiography/intervention indispensable? J Zhejiang Univ Sci B 2013; 14: 83, doi: 10.1631/jzus.B1200240.
5. Andrassy M, Volz HC, Schuessler A, Gitsioudis G, Hofmann N, Laohachewin D, et al. HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease. PLoS One 2012; 7: e52081, doi: 10.1371/journal.pone.0052081.
6. La Grutta L, Galia M, Gentile G, Lo Re G, Grassedonio E, Coppolino F, et al. Comparison of iodinated contrast media for the assessment of atherosclerotic plaque attenuation values by CT coronary angiography: observations in an ex vivo model. Br J Radiol 2013; 86: 20120238, doi: 10.1259/bjr.20120238.
7. Karshovska E, Weber C. Atherosclerosis: cell biology and lipoproteins - new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells. Curr Opin Lipidol 2012; 23: 400-401, doi: 10.1097/MOL.0b013e3283555a9c.
8. Calvert PA, Obaid DR, O’Sullivan M, Shapiro LM, McNab D, Densem CG, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging 2011; 4: 894-901, doi: 10.1016/j.jcmg.2011.05.005.
9. Nie P, Li D, Hu L, Jin S, Yu Y, Cai Z, et al. Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors. PLoS One 2014; 9: e97009, doi: 10.1371/journal.pone.0097009.
10. Recio C, Oguiza A, Lazaro I, Mallavia B, Egido J, Gomez- Guerrero C. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice. Arterioscler Thromb Vasc Biol 2014; 34: 1953-1960, doi: 10.1161/ATVBAHA.114.304144.
11. Koenen RR, Weber C. Chemokines: established and novel targets in atherosclerosis. EMBO Mol Med 2011; 3: 713-725, doi: 10.1002/emmm.201100183.
12. Tellez A, Schuster DS, Alviar C, Lopez-Berenstein G, Sanguino A, Ballantyne C, et al. Intramural coronary lipid injection induces atheromatous lesions expressing proinflammatory chemokines: implications for the development of a porcine model of atherosclerosis. Cardiovasc Revasc Med 2011; 12: 304-311, doi: 10.1016/j.carrev.2011.03.007.
13. Rayner KJ, Moore KJ. The plaque ‘‘micro’’ environment: microRNAs control the risk and the development of atherosclerosis. Curr Atheroscler Rep 2012; 14: 413-421, doi: 10.1007/s11883-012-0272-x.
14. Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, et al. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging 2012; 5: 681-689, doi: 10.1016/j.jcmg.2012.03.013.
15. Purushothaman KR, Purushothaman M, Levy AP, Lento PA, Evrard S, Kovacic JC, et al. Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis. J Am Coll Cardiol 2012; 60: 112-119, doi: 10.1016/j.jacc.2012.04.011.
16. Ueda Y. [Evaluation of atherosclerosis by IVUS and angioscopy]. Nihon Rinsho 2011; 69 (Suppl 1): 496-502.
17. Poupel L, Combadiere C. [Atherosclerosis: on the trail of chemokines]. Biol Aujourdhui 2010; 204: 285-293, doi: 10.1051/jbio/2010026.
18. Koenen RR, Weber C. Platelet-derived chemokines in vascular remodeling and atherosclerosis. Semin Thromb Hemost 2010; 36: 163-169, doi: 10.1055/s-0030-1251500.
19. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009; 15: 97-103, doi: 10.1038/nm.1898.
20. Lee CH, Tai BC, Lim GH, Chan MY, Low AF, Tan KC, et al. Correlation between high density lipoprotein-cholesterol and remodeling index in patients with coronary artery disease: IDEAS (IVUS diagnostic evaluation of atherosclerosis in Singapore)-HDL study. Int J Cardiovasc Imaging 2012; 28: 33-41.
21. Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis CF, et al. Regression of atherosclerosis is characterized by broad changes in the plaquemacrophage transcriptome. PLoS One 2012; 7: e39790, doi: 10.1371/journal.pone.0039790.
22. Correa CR, Dias-Melicio LA, Calvi SA, Lastoria S, Soares AM. Activation of monocytes and cytokine production in patients with peripheral atherosclerosis obliterans. J Inflamm 2011; 8: 23, doi: 10.1186/1476-9255-8-23.
23. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, et al. Impact of diabetes mellitus on coronary atherosclerosis and plaque composition under statin therapy - subanalysis of the TRUTH study. Circ J 2012; 76: 2188-2196, doi: 10.1253/circj.CJ-11-1303.
24. Zernecke A, Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res 2010; 86: 192-201, doi: 10.1093/cvr/cvp391.
25. Sun W, Wang G, Zhang ZM, Zeng XK, Wang X. Chemokine RANTES is upregulated in monocytes from patients with hyperhomocysteinemia. Acta Pharmacol Sin 2005; 26: 1317-1321, doi: 10.1111/j.1745-7254.2005.00178.x.